Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 0 | $0 |
| Sells | 25 | $14,410,290 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 11 Mar 2024 17:10 | KRTX | Karuna Therapeutics Inc | BRANNAN STEPHEN K. | Chief Medical Officer | 08 Mar 2024 | Sale | 100 | 318.96 | 31,896 | D |
| 11 Mar 2024 17:10 | KRTX | Karuna Therapeutics Inc | BRANNAN STEPHEN K. | Chief Medical Officer | 08 Mar 2024 | Sale | 4,900 | 318.33 | 1,559,817 | D |
| 12 Feb 2024 17:09 | KRTX | Karuna Therapeutics Inc | BRANNAN STEPHEN K. | Chief Medical Officer | 08 Feb 2024 | Sale | 818 | 316.56 | 258,946 | D |
| 12 Feb 2024 17:09 | KRTX | Karuna Therapeutics Inc | BRANNAN STEPHEN K. | Chief Medical Officer | 08 Feb 2024 | Sale | 4,182 | 316.05 | 1,321,721 | D |
| 09 Jan 2024 16:34 | KRTX | Karuna Therapeutics Inc | BRANNAN STEPHEN K. | Chief Medical Officer | 08 Jan 2024 | Sale | 15,000 | 316.81 | 4,752,150 | D |
| 12 Dec 2023 16:56 | KRTX | Karuna Therapeutics Inc | BRANNAN STEPHEN K. | Chief Medical Officer | 08 Dec 2023 | Sale | 99 | 204.18 | 20,214 | D |
| 12 Dec 2023 16:56 | KRTX | Karuna Therapeutics Inc | BRANNAN STEPHEN K. | Chief Medical Officer | 08 Dec 2023 | Sale | 2,251 | 203.8 | 458,754 | D |
| 12 Dec 2023 16:56 | KRTX | Karuna Therapeutics Inc | BRANNAN STEPHEN K. | Chief Medical Officer | 08 Dec 2023 | Sale | 3,969 | 202.74 | 804,675 | D |
| 12 Dec 2023 16:56 | KRTX | Karuna Therapeutics Inc | BRANNAN STEPHEN K. | Chief Medical Officer | 08 Dec 2023 | Sale | 2,116 | 201.73 | 426,861 | D |
| 12 Dec 2023 16:56 | KRTX | Karuna Therapeutics Inc | BRANNAN STEPHEN K. | Chief Medical Officer | 08 Dec 2023 | Sale | 1,565 | 200.11 | 313,172 | D |
| 13 Nov 2023 17:15 | KRTX | Karuna Therapeutics Inc | BRANNAN STEPHEN K. | Chief Medical Officer | 08 Nov 2023 | Sale | 2,245 | 180.08 | 404,280 | D |
| 13 Nov 2023 17:15 | KRTX | Karuna Therapeutics Inc | BRANNAN STEPHEN K. | Chief Medical Officer | 08 Nov 2023 | Sale | 808 | 178.9 | 144,551 | D |
| 13 Nov 2023 17:15 | KRTX | Karuna Therapeutics Inc | BRANNAN STEPHEN K. | Chief Medical Officer | 08 Nov 2023 | Sale | 265 | 177.14 | 46,942 | D |
| 13 Nov 2023 17:15 | KRTX | Karuna Therapeutics Inc | BRANNAN STEPHEN K. | Chief Medical Officer | 08 Nov 2023 | Sale | 1,281 | 174.11 | 223,035 | D |
| 13 Nov 2023 17:15 | KRTX | Karuna Therapeutics Inc | BRANNAN STEPHEN K. | Chief Medical Officer | 08 Nov 2023 | Sale | 401 | 175.69 | 70,452 | D |
| 10 Oct 2023 16:53 | KRTX | Karuna Therapeutics Inc | BRANNAN STEPHEN K. | Chief Medical Officer | 09 Oct 2023 | Sale | 3,256 | 172.96 | 563,158 | D |
| 10 Oct 2023 16:53 | KRTX | Karuna Therapeutics Inc | BRANNAN STEPHEN K. | Chief Medical Officer | 09 Oct 2023 | Sale | 1,744 | 173.77 | 303,055 | D |
| 11 Sep 2023 17:05 | KRTX | Karuna Therapeutics Inc | BRANNAN STEPHEN K. | Chief Medical Officer | 08 Sep 2023 | Sale | 60 | 185.6 | 11,136 | D |
| 11 Sep 2023 17:05 | KRTX | Karuna Therapeutics Inc | BRANNAN STEPHEN K. | Chief Medical Officer | 08 Sep 2023 | Sale | 908 | 185.03 | 168,007 | D |
| 11 Sep 2023 17:05 | KRTX | Karuna Therapeutics Inc | BRANNAN STEPHEN K. | Chief Medical Officer | 08 Sep 2023 | Sale | 2,756 | 184.13 | 507,462 | D |
| 11 Sep 2023 17:05 | KRTX | Karuna Therapeutics Inc | BRANNAN STEPHEN K. | Chief Medical Officer | 08 Sep 2023 | Sale | 1,276 | 183.07 | 233,597 | D |
| 10 Aug 2023 16:04 | KRTX | Karuna Therapeutics Inc | BRANNAN STEPHEN K. | Chief Medical Officer | 08 Aug 2023 | Sale | 1,250 | 181.5 | 226,875 | D |
| 10 Aug 2023 16:04 | KRTX | Karuna Therapeutics Inc | BRANNAN STEPHEN K. | Chief Medical Officer | 08 Aug 2023 | Sale | 1,355 | 180.93 | 245,160 | D |
| 10 Aug 2023 16:04 | KRTX | Karuna Therapeutics Inc | BRANNAN STEPHEN K. | Chief Medical Officer | 08 Aug 2023 | Sale | 2,395 | 179.53 | 429,974 | D |
| 12 Apr 2023 16:47 | KRTX | Karuna Therapeutics Inc | BRANNAN STEPHEN K. | Chief Medical Officer | 10 Apr 2023 | Sale | 5,000 | 176.88 | 884,400 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)